Covered recipient · General Payments record
SHANZAY HAIDER
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2023–2024
$641.28
- Reported across 28 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $516.86 | 22 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $290.59 | 11 |
| Corcept Therapeutics | $46.80 | 2 |
| Xeris Pharmaceuticals, Inc. | $39.89 | 2 |
| Bayer HealthCare Pharmaceuticals Inc. | $33.23 | 2 |
| DEXCOM, INC. | $32.64 | 1 |
| RECORDATI_RARE_DISEASES_INC. | $23.87 | 1 |
| Novo Nordisk AS | $18.65 | 1 |
| Antares Pharma, Inc. | $16.56 | 1 |
| Lilly USA, LLC | $14.63 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (22)
Sorted by paying entity, then date · as published by CMS
Program year 2024 2023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $11.65 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103863033 | CMS |
| ABBVIE INC. | $32.16 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103863035 | CMS |
| ABBVIE INC. | $34.66 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103863037 | CMS |
| ABBVIE INC. | $27.11 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103863039 | CMS |
| ABBVIE INC. | $30.36 | 04/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103863041 | CMS |
| ABBVIE INC. | $30.61 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103863043 | CMS |
| ABBVIE INC. | $29.35 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103863045 | CMS |
| ABBVIE INC. | $9.47 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103863047 | CMS |
| ABBVIE INC. | $27.43 | 06/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103863049 | CMS |
| ABBVIE INC. | $25.66 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103863051 | CMS |
| ABBVIE INC. | $32.13 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103863053 | CMS |
| Antares Pharma, Inc. | $16.56 | 06/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146462084 | CMS |
| Bayer Healthcare Pharmaceuticals Inc. | $15.63 | 03/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086139373 | CMS |
| Bayer Healthcare Pharmaceuticals Inc. | $17.60 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086249998 | CMS |
| Corcept Therapeutics | $25.60 | 01/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117786909 | CMS |
| Corcept Therapeutics | $21.20 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117786925 | CMS |
| Dexcom, Inc. | $32.64 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153335759 | CMS |
| Lilly USA, LLC | $14.63 | 01/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135374376 | CMS |
| Novo Nordisk Inc | $18.65 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096891711 | CMS |
| RECORDATI_RARE_DISEASES_INC. | $23.87 | 04/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139163036 | CMS |
| Xeris Pharmaceuticals, Inc. | $18.21 | 01/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144613222 | CMS |
| Xeris Pharmaceuticals, Inc. | $21.68 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144613224 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2023, 2024
- Source files
- Dataset page · Bulk file · PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.